Consistent with our new findings on the ability of STAT2 to inhibit STING-dependent signaling, there is a significant association between high levels of STAT2 in tumors and shorter overall survival in patients with lung adenocarcinomas (SI Appendix, Fig. S6C). Here, STAT2 is linked to lung adenocarcinoma.